Home > Boards > Free Zone > User's Groups > Just the Facts - Searching for the Next 10B

$HPNN: Hop-on and United Cannabis Sign Contract

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
MaxPowerLove$Ihub Member Profile
 
Followed By 2,024
Posts 227,369
Boards Moderated 42
Alias Born 06/14/10
160x600 placeholder
MaxPowerLove$Ihub   Tuesday, 10/07/14 09:42:10 AM
Re: None
Post # of 3535 


$HPNN: Hop-on and United Cannabis Sign Contract
Date : 05/19/2014 @ 11:40AM
Source : Marketwired
Stock : Hop-on, Inc. (PC) (HPNN)


Hop-on and United Cannabis Sign Contract

Re-Medical Finds Partner for Standardized Strains, Regional Production

TEMECULA, CA--(Marketwired - May 19, 2014) - Hop-on, Inc. (OTC Pink: HPNN) (PINKSHEETS: HPNN) is pleased to announce today that an agreement has been reached with United Cannabis Corporation, Inc. (UCANN) (OTC Pink: CNAB) (PINKSHEETS: CNAB) to assist with a regional rollout in the multibillion dollar Cannabis market utilizing their licensed partners' prolific catalog of award winning CBD-dominant and THC:CBD strains and world class cultivation expertise.

UCANN was selected as a strategic partner for their expertise in the medical and recreational Cannabis marketplace, their numerous regional partners that are state licensed and have been vetted for quality, consistency, and business ethics, and the fact that they are actively expanding from Colorado to other markets as they become viable. UCANN will assist in provisioning exclusive Cannabis cultivars that meet the stringent needs of Re-Medical's standardized cannabinoid profiles, and provide assistance in the build-out of processing, extraction, and production facilities, and regional sales and distribution operations for Re-Medical's cannabinoid therapies.

Re-Medical will provide licensing of intellectual property, where appropriate, regarding standardized cannabinoid profiles that show empirical or clinical efficacy as treatment for specific ailments, standardized cannabinoid profile extraction methods, efficient extraction of active ingredients from Cannabis using supercritical CO2 fluid extraction technologies, and the formulation and fabrication of transdermal and other innovative cannabinoid delivery technologies.

The market for CBD and other cannabinoid therapies is just beginning to be tapped, with over $600 million in annual sales expected this year in Colorado alone. With the entrance of more regions into the self-regulated cannabis marketplace, and the use of curated strains, professional production and processing methods, and rigorous testing standards, the market currently valued at $1.53 billion is projected to grow 68% to $2.57 billion by the end of 2014.

Peter Michaels, Hop-on CEO, stated, "As strategic partners, Re-Medical and UCANN have the combined resources, experience, and intellectual property to fulfill the longstanding dreams of many who have suffered far too long in a marketplace without standards. Together, we bring a force for quality, safety, efficacy, and a true passion to end needless suffering. It's an amazing thing when what's great for business is also great for society."

About Hop-on, Inc.
Hop-on, Inc. is a global ODM and OEM manufacturer of electronics, based in the United States. Over the past 20 years, Hop-on has successfully secured essential patents for mobile communications and computing technologies, and is respected for developing the world's first disposable cell phone. Hop-on's focus on smartphones and innovative mobile device applications is bringing cost friendly solutions to today's demanding world market. Hop-on is also diversified in nutraceutical and cannabinoid technologies through its subsidiary Re-Medical, Inc. For more information, please visit www.hop-on.com and www.re-medical.com

About UCANN
United Cannabis Corporation has a foundation in the cannabis industries. With our consulting services, management and oversight we are capable of assisting any Cannabis oriented company on any scale. United Cannabis Corporation is now partnering domestically and internationally with local businessmen, entrepreneurs, scientists, and government agencies for the purpose of promoting Best Practices in Planning, Procedures, Governance and Patient Care. Consulting and providing guidance on design and construction of growth facilities and cultivation of medical grade cannabis-based products worldwide. With access to a catalog of award winning genetics and coupled with our leadership & experience we are positioned to take any Cannabis Business through all of the steps for success. For further information, please visit www.unitedcannabis.us

Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

Additional Information
For additional information, please contact
Shareholder Services
(949) 756-9008
Email contact@hop-on.com



- Go HPNN

===========================================================

$HPNN: Hop-on Shareholder Meeting Update
Date : 05/20/2014 @ 1:45PM
Source : Marketwired
Stock : Hop-on, Inc. (PC) (HPNN)


Hop-on Shareholder Meeting Update

Hop-on Identifies 170 OEMs and ODMs for IP Licensing

TEMECULA, CA--(Marketwired - May 20, 2014) - Hop-on, Inc. (OTC Pink: HPNN) (PINKSHEETS: HPNN) a global electronics OEM, is pleased to announce today that its shareholder meeting held on May 16, 2014 was a successful opportunity to interact with shareholders regarding recent developments. The format of the meeting allowed for an open and broad-ranging discussion to address Company progress and concerns.

The Company has put out several news releases in recent months, and the purpose of the shareholder meeting was to review the Company's positive developments and lay out the plans for its future.

The agenda items covered were

1. Update on the intellectual property royalty agreement with Microsoft.

2. Closing of the Company's first IPR deal with Teleepoch

3. Update on IPR negotiations with 12 Chinese and Taiwanese OEMs

4. Update on 170 companies Hop-on will be pursuing for licensing arrangements

5. Retirement of significant portions of Company debt

6. Plans for spin-off of Re-Medical subsidiary to fully reporting public BB company

7. CTO summarized Re-Medical's proprietary cannabinoid therapies and delivery technologies

8. Plans for Re-Medical IP licensing arrangements and operations in Colorado

9. Plans for USACig subsidiary

10. Plans for adjusting the capital structure of the Company, including dispelling false rumors of a pending reverse stock split

11. At the insistence of shareholders, Mr. Michaels addressed concerns regarding a stalker harassing him using different aliases on the Internet. Mr. Michaels acknowledged in response to shareholder concerns that law enforcement is investigating this individual. The shareholders were also informed regarding status of an extortion attempt by one internet poster earlier this year.


Peter Michaels, President of Hop-on stated, "I was pleased with our shareholder turnout at the meeting, and even more pleased about the positive response and outlook of our investors. I also appreciate the support from our shareholders."

ABOUT HOP-ON, INC.
Hop-on, Inc. is a global ODM and OEM manufacturer of electronics, based in the United States. Over the past 20 years, Hop-on has successfully secured essential patents for mobile communications and computing technologies, and is respected for developing the world's first disposable cell phone. Hop-on's focus on smartphones and innovative mobile device applications is bringing cost friendly solutions to today's demanding world market. Hop-on is also diversified in nutraceutical and cannabinoid technologies through its subsidiary Re-Medical, Inc. For more information, please visit www.hop-on.com and www.re-medical.com

Safe Harbor
This press release contains forward looking statements pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements include risks and uncertainties that may cause the company's plans to change and are in no way intended to guarantee that the company will be successful in executing its plans. Hop-on, Inc. common stock currently trades on the over-the-counter "Pink Sheets" under the symbol HPNN. This press release in no way constitutes any recommendation regarding the securities of HPNN or its affiliates. Any person reading this press release is advised that this release should be considered in the light of all facts and circumstances regarding the business and financial condition and prospects of HPNN, and no inference has been made that this release contains all such information.

Additional Information
For additional information, please contact
Peter Michaels
(949) 756-9008
Email contact@hop-on.com



- Go HPNN


Disclaimer: Alcohol is for those who could afford to lose some valuable brain cells.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist